Maternal exposure to TNF inhibition does not significantly increase infection risk in newborns, according to findings ...

Investigators examine the effectiveness of TNF inhibitors on pregnant women and their risk of infection outcomes.

In utero exposure to TNF inhibitors among offspring born to mothers with chronic inflammatory diseases was not associated with an increased risk for serious infections. However, among those exposed to ...

TNF inhibitors were used by 64% of pregnant women with inflammatory diseases through all trimesters. Those with continuous use through all trimesters had reduced use of corticosteroids postpartum.

Dr. Beth Jonas answers the question: 'Anti-TNF Meds For Rheumatoid Arthritis?' — -- Question: What are anti-tumor necrosis factor (anti-TNF) medications and how are they used to treat rheumatoid ...

Please provide your email address to receive an email when new articles are posted on . Patients with rheumatoid arthritis and high disease perception in the brain are more likely to respond to TNF ...

Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have identified TNF-α inhibitors reported to be useful for the treatment of autoimmune diseases.

The FDA updated the indication of the JAK inhibitor upadacitinib (Rinvoq) in inflammatory bowel disease (IBD) to account for cases where a patient may not be appropriate for a TNF blocker, drugmaker ...